| P50 | author | Sujata M Bhavnani | Q117481064 |
| | Arnold Louie | Q125021748 |
| P2093 | author name string | Paul G Ambrose | |
| | George L Drusano | |
| | Joseph S Bertino | |
| | Ann N Nafziger | |
| P2860 | cites work | Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring | Q34061646 |
| | Nonparametric approach to population pharmacokinetics in oncology patients receiving aminoglycoside therapy | Q35814454 |
| | Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 |
| | Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia | Q40925796 |
| | The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess | Q42208982 |
| | Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone | Q43459102 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections | Q54297609 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 753-760 | |
| P577 | publication date | 2007-08-08 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Back to the future: using aminoglycosides again and how to dose them optimally | |
| P478 | volume | 45 | |